RIDHO: “Radiomics and Integration of Heterogenous Data in Oncology”
General information :
Funding: FUI 23/Bpifrance – Paris Region
Supporting clusters: Medicen (leading cluster), Systematic (co-supporter)
Budget: €4.2 M
Duration: 3 months
- Companies: Philips HealthTech, Evolucare Technologies, Ariana Pharma
- Hospitals: APHP (Georges Pompidou European Hospital and Beaujon Hospital)
Oncology, precision medicine, support with therapeutic strategy, personalized medicine
Radiomics, image analysis, data mining, artificial intelligence, predictive algorithms
The main innovation of the RIHDO project is to use radiomics to integrate the potential of imaging with approaches based on the integration and analysis of heterogenous data. The radiomic characteristics extracted from images will increase the total patient characterization data (clinical, biological), which will make it possible to extract multi-marker signatures and prognostic or diagnostic prediction models from it, based on the clinical question that is asked.
The proposed technology has already demonstrated its potential in academia and research and RIHDO intends to demonstrate its feasibility in a clinical care setting.